Recent Articles

April 21, 2016 10:23 am
Ryan Bushey, Digital Editor
This disease marks the third treatment indication GW is pursuing.
April 20, 2016 4:39 pm
Stephanie Guzowski, Editor
Vice President Biden encouraged the nation’s leading cancer researchers to collaborate more effectively and to share data, as well as provide him with direction, in efforts to accelerate ambitious cancer research goals.
April 19, 2016 8:40 am
Dan Roberts, Ph.D., Senior Oncology & Hematology Analyst, GlobalData
Immuno-oncology products have demonstrated comparable respective efficacy and safety profiles.
April 18, 2016 9:27 am
Ryan Bushey, Digital Editor
These results bode well for individuals suffering from this disease. 
April 14, 2016 10:39 am
Ryan Bushey, Digital Editor
Scientists discovered this over-the-counter drug could have special properties. 
April 14, 2016 8:45 am
Ryan Bushey, Digital Editor
Stanford, Memorial Sloan Kettering Cancer Center, and the University of Pennsylvania are some of the institutions taking part in this endeavor.
April 13, 2016 9:50 am
Dr. Michael Kiebish, Chief Precision Medicine Officer, BERG Health
In the new frontier of precision medicine, today’s explorers do not emulate Ferdinand Magellan, Vasco da Gama, John Smith, or Neil Armstrong, wielding armor and protective gear to combat attackers or the elements. 
April 12, 2016 4:05 pm
Ryan Bushey, Digital Editor
The drug is intended to relieve patients who experience pain, without inducing the psychotropic side effects associated with marijuana.
April 11, 2016 10:18 am
Dante J. Marciani, Sc.D., Ph.D.; President & CSO, Qantu Therapeutics
Proteopathies or proteinopathies are diseases where misfolded proteins adopt aberrant conformations that interfere with their normal functions causing organ damage, e.g. Alzheimer’s disease (AD). While many proteopathies are neurodegenerative, they also cause disorders like type 2 diabetes, which may have genetic risk factors. Read more...
April 7, 2016 10:04 am
Ryan Bushey, Digital Editor
The partnership was revealed hours after Pfizer merger officially ended. Read more...
Subscribe to Drug Discovery & Development